The DOI matches its Crossref record; 81 of the 81 references it cites were found in a registry or an index.
Non-alcoholic fatty liver disease: an overview of prevalence, diagnosis, pathogenesis and treatment considerations
Abstract
The global increase in the prevalence of obesity has heralded a rise in associated liver injury namely NAFLD (non-alcoholic fatty liver disease). It is estimated that 20–30% of adult populations in developed countries have NAFLD and, although high quality data is currently lacking, the condition is clearly increasing in children also. NAFLD should be suspected in those with commonly available simple clinical signs and biochemistry consistent with insulin resistance. A small number of individuals with NAFLD, often considered a relatively benign condition, will progress to more severe stages of liver disease including NASH (non-alcoholic steatohepatitis) with or without fibrosis, cirrhosis and occasionally hepatocellular carcinoma. NAFLD is also commonly associated with an increased risk of developing Type 2 diabetes and treatable features of insulin resistance such as dyslipidaemia and dysglycaemia. Histological examination of liver tissue remains the only proven method to distinguish between simple steatosis and NASH, a condition far more likely to progress to cirrhosis. Identification of an imaging technique or non-invasive marker to achieve this distinction is therefore much sought after and would allow larger clinical trials and better clinical assessment. Case series and pilot studies of lifestyle advice, insulin sensitizers and other medications have shown improvements in liver histology and serum liver enzymes but robust randomized controlled studies are needed. Furthermore, the cost/benefit ratio of any new therapies, and any potential harms, must be evaluated carefully before being clinically advocated.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Design and validation of a histological scoring system for nonalcoholic fatty liver disease†
Kleiner, D. E., Brunt, E. M., Van Natta, M., Behling, C., Contos, M. J., Cummings, O. W., Ferrell, L. D., Liu, Y., Torbenson, M. S., Unalp‐Arida, A., et al. (2005) · Hepatology · doi:10.1002/hep.20701 · Cited by 10,791
Nonalcoholic Fatty Liver Disease
Angulo, P. (2002) · New England Journal of Medicine · doi:10.1056/nejmra011775 · Cited by 5,228
Effect of Rosiglitazone on the Risk of Myocardial Infarction and Death from Cardiovascular Causes
Nissen, S. E., & Wolski, K. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa072761 · Cited by 4,675
Prevalence of Hepatic Steatosis in An Urban Population in the United States: Impact of Ethnicity
Browning, J. D., Szczepaniak, L. S., Dobbins, R., Nuremberg, P., Horton, J. D., Cohen, J. C., Grundy, S. M., & Hobbs, H. H. (2004) · Hepatology · doi:10.1002/hep.20466 · Cited by 3,664
Donnelly, K. L., Smith, C. I., Schwarzenberg, S. J., Jessurun, J., Boldt, M. D., & Parks, E. J. (2005) · Journal of Clinical Investigation · doi:10.1172/jci23621 · Cited by 3,604
Local and systemic insulin resistance resulting from hepatic activation of IKK-β and NF-κB
Cai, D., Yuan, M., Frantz, D. F., Melendez, P. A., Hansen, L., Lee, J., & Shoelson, S. E. (2005) · Nature Medicine · doi:10.1038/nm1166 · Cited by 2,245
Nonalcoholic Steatohepatitis: Summary of An Aasld Single Topic Conference
Neuschwander-Tetri, B. A., & Caldwell, S. H. (2003) · Hepatology · doi:10.1053/jhep.2003.50193 · Cited by 2,154
The utility of radiological imaging in nonalcoholic fatty liver disease
Saadeh, S., Younossi, Z. M., Remer, E. M., Gramlich, T., Ong, J. P., Hurley, M., Mullen, K. D., Cooper, J. N., & Sheridan, M. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.35354 · Cited by 2,110
A placebo-controlled trial of pioglitazone in subjects with nonalcoholic steatohepatitis
Belfort, R., Harrison, S. A., Brown, K., Darland, C., Finch, J., Hardies, J., Balas, B., Gastaldelli, A., Tio, F., Pulcini, J., et al. (2006) · New England Journal of Medicine · doi:10.1056/nejmoa060326 · Cited by 1,827
Independent predictors of liver fibrosis in patients with nonalcoholic steatohepatitis
Angulo, P., Keach, J. C., Batts, K. P., & Lindor, K. D. (1999) · Hepatology · doi:10.1002/hep.510300604 · Cited by 1,610
Prevalence of Fatty Liver in Children and Adolescents
Schwimmer, J. B., Deutsch, R., Kahen, T., Lavine, J. E., Stanley, C., & Behling, C. (2006) · Pediatrics · doi:10.1542/peds.2006-1212 · Cited by 1,481
Dresner, A., Laurent, D., Marcucci, M., Griffin, M. E., Dufour, S., Cline, G. W., Slezak, L. A., Andersen, D. K., Hundal, R. S., Rothman, D. L., et al. (1999) · Journal of Clinical Investigation · doi:10.1172/jci5001 · Cited by 1,311
Diagnosis of cirrhosis by transient elastography (FibroScan): a prospective study
Foucher, J. (2006) · Gut · doi:10.1136/gut.2005.069153 · Cited by 1,284
Prevalence of and Risk Factors for Hepatic Steatosis in Northern Italy
Bellentani, S., Saccoccio, G., Masutti, F., Crocè, L. S., Brandi, G., Sasso, F., Cristanini, G., & Tiribelli, C. (2000) · Annals of Internal Medicine · doi:10.7326/0003-4819-132-2-200001180-00004 · Cited by 1,265
Nonalcoholic steatohepatitis: An expanded clinical entity
Bacon, B. R., Farahvash, M. J., Janney, C. G., & Neuschwander-Tetri, B. A. (1994) · Gastroenterology · doi:10.1016/0016-5085(94)90235-6 · Cited by 1,144
AGA technical review on nonalcoholic fatty liver disease
Sanyal, A. J. (2002) · Gastroenterology · doi:10.1053/gast.2002.36572 · Cited by 1,072
Liver fibrosis in overweight patients
Ratziu, V., Giral, P., Charlotte, F., Bruckert, E., Thibault, V., Theodorou, I., Khalil, L., Turpin, G., Opolon, P., & Poynard, T. (2000) · Gastroenterology · doi:10.1016/s0016-5085(00)70364-7 · Cited by 973
Rosiglitazone Evaluated for Cardiovascular Outcomes — An Interim Analysis
Home, P. D., Pocock, S. J., Beck-Nielsen, H., Gomis, R., Hanefeld, M., Jones, N. P., Komajda, M., & McMurray, J. J. V. (2007) · New England Journal of Medicine · doi:10.1056/nejmoa073394 · Cited by 761
Musso, G., Gambino, R., De Michieli, F., Cassader, M., Rizzetto, M., Durazzo, M., Fagà, E., Silli, B., & Pagano, G. (2003) · Hepatology · doi:10.1053/jhep.2003.50132 · Cited by 759
Neuschwander-Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Oliver, D., & Bacon, B. R. (2003) · Hepatology · doi:10.1002/hep.1840380427 · Cited by 751
Histopathology of Pediatric Nonalcoholic Fatty Liver Disease * #
Schwimmer, J. B., Behling, C., Newbury, R., Deutsch, R., Nievergelt, C., Schork, N. J., & Lavine, J. E. (2005) · Hepatology · doi:10.1002/hep.20842 · Cited by 747
Vitamin E and vitamin C treatment improves fibrosis in patients with nonalcoholic steatohepatitis
Harrison, S. A., Torgerson, S., Hayashi, P. H., Ward, J. A., & Schenker, S. (2003) · The American Journal of Gastroenterology · doi:10.1016/j.amjgastroenterol.2003.08.005 · Cited by 731
Nonalcoholic fatty liver disease: Improvement in liver histological analysis with weight loss
Dixon, J. B., Bhathal, P. S., Hughes, N. R., & O'Brien, P. E. (2004) · Hepatology · doi:10.1002/hep.20251 · Cited by 727
A pilot study of pioglitazone treatment for nonalcoholic steatohepatitis
Promrat, K., Lutchman, G., Uwaifo, G. I., Freedman, R. J., Soza, A., Heller, T., Doo, E., Ghany, M., Premkumar, A., Park, Y., et al. (2004) · Hepatology · doi:10.1002/hep.20012 · Cited by 726
Bugianesi, E., Gentilcore, E., Manini, R., Natale, S., Vanni, E., Villanova, N., David, E., Rizzetto, M., & Marchesini, G. (2005) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2005.41583.x · Cited by 691
Drinking habits as cofactors of risk for alcohol induced liver damage
Bellentani, S., Saccoccio, G., Costa, G., Tiribelli, C., Manenti, F., Sodde, M., Croce’, L. S., Sasso, F., Pozzato, G., Cristianini, G., et al. (1997) · Gut · doi:10.1136/gut.41.6.845 · Cited by 630
Therapeutic effects of restricted diet and exercise in obese patients with fatty liver
Ueno, T., Sugawara, H., Sujaku, K., Hashimoto, O., Tsuji, R., Tamaki, S., Torimura, T., Inuzuka, S., Sata, M., & Tanikawa, K. (1997) · Journal of Hepatology · doi:10.1016/s0168-8278(97)80287-5 · Cited by 609
Ruhl, C. E., & Everhart, J. E. (2003) · Gastroenterology · doi:10.1053/gast.2003.50004 · Cited by 596
Laurin, J., Lindor, K. D., Crippin, J. S., Gossard, A., Gores, G. J., Ludwig, J., Rakela, J., & McGill, D. B. (1996) · Hepatology · doi:10.1002/hep.510230624 · Cited by 566
Comparison of liver histology with ultrasonography in assessing diffuse parenchymal liver disease
Joseph, A. E. A., Saverymuttu, S. H., Al-Sam, S., Cook, M. G., & Maxwell, J. D. (1991) · Clinical Radiology · doi:10.1016/s0009-9260(05)80350-2 · Cited by 515
Natural history of nonalcoholic steatohepatitis: A longitudinal study of repeat liver biopsies
Fassio, E., �lvarez, E., Dom�nguez, N., Landeira, G., & Longo, C. (2004) · Hepatology · doi:10.1002/hep.20410 · Cited by 469
Yokohama, S., Yoneda, M., Haneda, M., Okamoto, S., Okada, M., Aso, K., Hasegawa, T., Tokusashi, Y., Miyokawa, N., & Nakamura, K. (2004) · Hepatology · doi:10.1002/hep.20420 · Cited by 458
Jimba, S., Nakagami, T., Takahashi, M., Wakamatsu, T., Hirota, Y., Iwamoto, Y., & Wasada, T. (2005) · Diabetic Medicine · doi:10.1111/j.1464-5491.2005.01582.x · Cited by 455
Nonalcoholic Fatty Liver Disease: An Underrecognized Cause of Cryptogenic Cirrhosis
Clark, J. M., & Diehl, A. M. (2003) · JAMA · doi:10.1001/jama.289.22.3000 · Cited by 428
Tominaga, K., Kurata, J. H., Chen, Y. K., Fujimoto, E., Miyagawa, S., Abe, I., & Kusano, Y. (1995) · Digestive Diseases and Sciences · doi:10.1007/bf02208670 · Cited by 406
Metformin in the treatment of patients with non‐alcoholic steatohepatitis
Uygun, A., Kadayifci, A., Isik, A. T., Ozgurtas, T., Deveci, S., Tuzun, A., Yesilova, Z., Gulsen, M., & Dagalp, K. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.01888.x · Cited by 405
Influence of Gender, Race, and Ethnicity on Suspected Fatty Liver in Obese Adolescents
Schwimmer, J. B., McGreal, N., Deutsch, R., Finegold, M. J., & Lavine, J. E. (2005) · Pediatrics · doi:10.1542/peds.2004-1832 · Cited by 376
Sattar, N., Scherbakova, O., Ford, I., O’Reilly, D. S. J., Stanley, A., Forrest, E., MacFarlane, P. W., Packard, C. J., Cobbe, S. M., & Shepherd, J. (2004) · Diabetes · doi:10.2337/diabetes.53.11.2855 · Cited by 375
Self-citationEffect of weight reduction on hepatic abnormalities in overweight patients
Palmer, M., & Schaffner, F. (1990) · Gastroenterology · doi:10.1016/0016-5085(90)91169-7 · Cited by 374
Dufour, J., Oneta, C. M., Gonvers, J., Bihl, F., Cerny, A., Cereda, J., Zala, J., Helbling, B., Steuerwald, M., & Zimmermann, A. (2006) · Clinical Gastroenterology and Hepatology · doi:10.1016/j.cgh.2006.09.025 · Cited by 358
Westerbacka, J., Corn�r, A., Tiikkainen, M., Tamminen, M., Vehkavaara, S., H�kkinen, A.-M., Fredriksson, J., & Yki-J�rvinen, H. (2004) · Diabetologia · doi:10.1007/s00125-004-1460-1 · Cited by 338
Prevelance of abnormal serum aminotransferase values in overweight and obese adolescents
Strauss, R. S., Barlow, S. E., & Dietz, W. H. (2000) · The Journal of Pediatrics · doi:10.1016/s0022-3476(00)24645-3 · Cited by 329
The Role of Ultrasound in the Diagnosis of Hepatic Steatosis in Morbidly Obese Patients
Mottin, C. C., Moretto, M., Padoin, A. V., Swarowsky, A. M., Toneto, M. G., Glock, L., & Repetto, G. (2004) · Obesity Surgery · doi:10.1381/096089204323093408 · Cited by 301
Nonalcoholic steatohepatitis and cryptogenic cirrhosis within kindreds
Struben, V. M. D., Hespenheide, E. E., & Caldwell, S. H. (2000) · The American Journal of Medicine · doi:10.1016/s0002-9343(99)00315-0 · Cited by 296
Hepatic Enzymes, the Metabolic Syndrome, and the Risk of Type 2 Diabetes in Older Men
Wannamethee, S. G., Shaper, A. G., Lennon, L., & Whincup, P. H. (2005) · Diabetes Care · doi:10.2337/diacare.28.12.2913 · Cited by 274
Ekstedt, M., Franzén, L. E., Mathiesen, U. L., Holmqvist, M., Bodemar, G., & Kechagias, S. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.02.013 · Cited by 272
Selection and Outcome of Living Donors for Adult to Adult Right Lobe Transplantation
Marcos, A., Fisher, R. A., Ham, J. M., Olzinski, A. T., Shiffman, M. L., Sanyal, A. J., Luketic, V. A. C., Sterling, R. K., Olbrisch, M. E., & Posner, M. P. (2000) · Transplantation · doi:10.1097/00007890-200006150-00034 · Cited by 272
Benefits of lifestyle modification in NAFLD
Harrison, S. A., & Day, C. P. (2007) · Gut · doi:10.1136/gut.2006.112094 · Cited by 240
Ethnic Differences in the Prevalence of Cryptogenic Cirrhosis
Browning, J. D., Kumar, K. S., Saboorian, M. H., & Thiele, D. L. (2004) · American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2004.04059.x · Cited by 227
Palekar, N. A., Naus, R., Larson, S. P., Ward, J., & Harrison, S. A. (2006) · Liver International · doi:10.1111/j.1478-3231.2005.01209.x · Cited by 216
Dixon, J., Bhathal, P., & O'Brien, P. (2006) · Obesity Surgery · doi:10.1381/096089206778663805 · Cited by 212
Prevalence of abnormal serum aminotransferase values in overweight and obese adolescents
Strauss, R. S., Barlow, S. E., & Dietz, W. H. (2000) · Journal of Pediatrics · doi:10.1067/mpd.2000.102940 · Cited by 209
Effects of bariatric surgery on nonalcoholic fatty liver disease: Preliminary findings after 2 years
Furuya, C. K., De Oliveira, C. P. M. S., De Mello, E. S., Faintuch, J., Raskovski, A., Matsuda, M., Vezozzo, D. C. P., Halpern, A., Garrido, A. B., Alves, V. A. F., et al. (2007) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2007.04833.x · Cited by 193
A pilot study of orlistat treatment in obese, non‐alcoholic steatohepatitis patients
Harrison, S. A., Fincke, C., Helinski, D., Torgerson, S., & Hayashi, P. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02153.x · Cited by 191
Predictors of Nonalcoholic Steatohepatitis (NASH) in Obese Patients Undergoing Gastric Bypass
Boza, C., Riquelme, A., Ibañez, L., Duarte, I., Norero, E., Viviani, P., Soza, A., Fernandez, J. I., Raddatz, A., Guzman, S., et al. (2005) · Obesity Surgery · doi:10.1381/0960892055002347 · Cited by 183
Epidemiology of nonalcoholic fatty liver
Ruhl, C. E., & Everhart, J. E. (2004) · Clinics in Liver Disease · doi:10.1016/j.cld.2004.04.008 · Cited by 176
Natural History of NAFLD: Remarkably Benign in the Absence of Cirrhosis
Day, C. P. (2005) · Gastroenterology · doi:10.1053/j.gastro.2005.05.041 · Cited by 176
Shimada, M., Kawahara, H., Ozaki, K., Fukura, M., Yano, H., Tsuchishima, M., Tsutsumi, M., & Takase, S. (2007) · The American Journal of Gastroenterology · doi:10.1111/j.1572-0241.2007.01322.x · Cited by 163
Statins and hepatic steatosis: Perspectives from the Dallas Heart Study
Browning, J. D. (2006) · Hepatology · doi:10.1002/hep.21248 · Cited by 162
Bernard, S., Touzet, S., Personne, I., Lapras, V., Bondon, P.-J., Berthezène, F., & Moulin, P. (2000) · Diabetologia · doi:10.1007/s001250051481 · Cited by 156
Hatzitolios, A. I., Savopoulos, C., Lazaraki, G., Sidiropoulos, I., Haritanti, P., Lefkopoulos, A., Karagiannopoulou, G., Tzioufa, & Dimitrios, K. (2004) · PubMed · Cited by 154
Influence of TNF gene polymorphisms in Japanese patients with NASH and simple steatosis
Tokushige, K., Takakura, M., Tsuchiya-Matsushita, N., Taniai, M., Hashimoto, E., & Shiratori, K. (2007) · Journal of Hepatology · doi:10.1016/j.jhep.2007.01.028 · Cited by 149
Resolution of nonalcoholic steatohepatits after gastric bypass surgery
Liu, X., Lazenby, A. J., Clements, R. H., Jhala, N., & Abrams, G. A. (2007) · Obesity Surgery · doi:10.1007/s11695-007-9086-2 · Cited by 149
Novel biochemical risk factors for type 2 diabetes: pathogenic insights or prediction possibilities?
Sattar, N., Wannamethee, S. G., & Forouhi, N. G. (2008) · Diabetologia · doi:10.1007/s00125-008-0954-7 · Cited by 143
Self-citationGamma‐glutamyl transpeptidase and the metabolic syndrome
Rantala, A. O., Lilja, M., Kauma, H., Savolainen, M. J., Reunanen, A., & Kesäniemi, Y. A. (2000) · Journal of Internal Medicine · doi:10.1046/j.1365-2796.2000.00723.x · Cited by 140
Pacifico, L., Celestre, M., Anania, C., Paolantonio, P., Chiesa, C., & Laghi, A. (2007) · Acta Paediatrica · doi:10.1111/j.1651-2227.2007.00186.x · Cited by 133
Sattar, N., McConnachie, A., Ford, I., Gaw, A., Cleland, S. J., Forouhi, N. G., McFarlane, P., Shepherd, J., Cobbe, S., & Packard, C. (2007) · Diabetes · doi:10.2337/db06-1256 · Cited by 127
Self-citationSabuncu, T., Nazlıgül, Y., Karaoğlanoğlu, M., Uçar, E., & Kilic, F. B. (2003) · PubMed · Cited by 126
Park, J., Jeong, G., Kim, S. J., Kim, M. K., & Park, S. M. (2006) · Journal of Gastroenterology and Hepatology · doi:10.1111/j.1440-1746.2006.04758.x · Cited by 125
Neuschwander‐Tetri, B. A., Brunt, E. M., Wehmeier, K. R., Sponseller, C. A., Hampton, K., & Bacon, B. R. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00027-8 · Cited by 118
Georgescu, E. F., & Georgescu, M. (2007) · PubMed · Cited by 114
Non-alcoholic Steatohepatitis (NASH) and Hepatocellular Carcinoma
Cuadrado, A., Orive, A., García-Suárez, C., Domínguez, A., Fernández-Escalante, J. C., Crespo, J., & Pons‐Romero, F. (2005) · Obesity Surgery · doi:10.1381/0960892053576596 · Cited by 106
Obesity and metabolic disease: is adipose tissue the culprit?
Frayn, K. N. (2005) · Proceedings of The Nutrition Society · doi:10.1079/pns2004403 · Cited by 99
Tsuda, N., Okada, M., & Murakami, T. (2007) · Investigative Radiology · doi:10.1097/01.rli.0000258058.44876.a5 · Cited by 98
Andersen, T., Christoffersen, P., & Gluud, C. N. (1984) · PubMed · Cited by 96
Non-alcoholic fatty liver disease in obese children evaluated by magnetic resonance imaging
Radetti, G., Kleon, W., Stuefer, J., & Pittschieler, K. (2006) · Acta Paediatrica · doi:10.1080/08035250500449890 · Cited by 95
Cortez‐Pinto, H., & Camilo, M. (2004) · Best Practice & Research Clinical Gastroenterology · doi:10.1016/j.bpg.2004.06.021 · Cited by 93
Zib, I., Jacob, A. N., Lingvay, I., Salinas, K., McGavock, J., Raskin, P., & Szczepaniak, L. S. (2007) · Journal of Investigative Medicine · doi:10.2310/6650.2007.00003 · Cited by 80
Effect of weight control on hepatic abnormalities in obese patients with fatty liver
Park, H. S., Kim, M. W., & Shin, E. S. (1995) · Journal of Korean Medical Science · doi:10.3346/jkms.1995.10.6.414 · Cited by 75
Shneider, B. L., González‐Peralta, R. P., & Roberts, E. A. (2006) · Hepatology · doi:10.1002/hep.21373 · Cited by 60
Non-alcoholic steatohepatitis (NASH): approaching more tailored and effective therapies.
Portincasa, P. (2007) · PubMed · Cited by 6
Cited by
Pi-Sunyer, X. (2009) · Postgraduate Medicine · doi:10.3810/pgm.2009.11.2074 · Cited by 1,025
Pi-Sunyer, F. X. (2002) · Obesity Surgery · doi:10.1007/bf03342140 · Cited by 827
Pathogenesis of non-alcoholic fatty liver disease
Dowman, J. K., Tomlinson, J. W., & Newsome, P. N. (2010) · QJM · doi:10.1093/qjmed/hcp158 · Cited by 741
Plasma Metabolomic Profile in Nonalcoholic Fatty Liver Disease
Kalhan, S. C., Guo, L., Edmison, J., Dasarathy, S., McCullough, A. J., Hanson, R. W., & Milburn, M. (2011) · Metabolism · doi:10.1016/j.metabol.2010.03.006 · Cited by 532
Bruce, K. D., Cagampang, F. R., Argenton, M., Zhang, J., Ethirajan, P. L., Burdge, G. C., Bateman, A. C., Clough, G. F., Poston, L., Hanson, M. A., et al. (2009) · Hepatology · doi:10.1002/hep.23205 · Cited by 449
Metadata
- Authors
- Preiss, D., & Sattar, N.
- Venue
- Clinical Science
- Publisher
- Portland Press Ltd.
- Published
- 2008-08-01
- Volume
- 115
- Issue
- 5
- Pages
- 141-150
- ISSN
- 0143-5221 (ISSN-L)
- 1470-8736
- OpenAlex
- W2034619043
- Cited by
- 292
- References
- 81
- FWCI
- 19.93
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.